Skip to Content
Merck
All Photos(1)

Key Documents

SML3515

Sigma-Aldrich

Bulevirtide trifluoroacetate

≥98% (HPLC)

Synonym(s):

Myrcludex B trifluoroacetate, Myrcludex-B trifluoroacetate, N-Tetradecanoylglycyl-Thr-Asn-Leu-Ser-Val-Pro-Asn-Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro-Asn-Lys-Asp-His-Trp-Pro-Glu-Ala-Asn-Lys-Val-Gly-NH2 trifluoroacetate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C248H355N65O72 · xC2HF3O2
Molecular Weight:
5398.86 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

100

Assay

≥98% (HPLC)

form

(Powder or Lyophilized powder or film)

storage condition

desiccated

color

white to off-white

storage temp.

-10 to -25°C

Biochem/physiol Actions

Bulevirtide is a synthetic lipopeptide derived from the preS1 domain of the Hepatitis B virus (HBV) envelope protein that specifically binds to hepatocytes and efficiently blocks de novo HBV and its satellite virus hepatitis D (HDV) infection both in vitro and in vivo.
HDV and HBV virion entry inhibitor

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000414886
0000414886
0000326251
0000199376
0000205383

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bulevirtide for HBV and HDV infections
Yardeni D, Koh C
Drugs Today (Barc), 57(7), 433-448 (2021)
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Urban S, Neumann-Haefelin C, Lampertico P
Gut, 70, 1782-1794 (2021)
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
Journal of Hepatology, 58(5), 861-867 (2013)

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service